| 1 |
34657149 | Tyrosine phosphatases regulate resistance to ALK inhibitors in ALK+ anaplastic large cell lymphoma. | 2022 Feb 3 |
1 |
| 2 |
33887553 | Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor. | 2021 Jul |
1 |
| 3 |
32111984 | SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET. | 2020 Apr |
3 |
| 4 |
32484926 | Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition. | 2020 Aug 1 |
2 |
| 5 |
29444468 | A major component of vitamin E, α-tocopherol inhibits the anti-tumor activity of crizotinib against cells transformed by EML4-ALK. | 2018 Apr 15 |
1 |
| 6 |
29755689 | A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapy. | 2018 Apr 17 |
1 |
| 7 |
27753543 | STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer. | 2016 Dec 16 |
3 |
| 8 |
26384345 | Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines. | 2015 Nov 24 |
5 |
| 9 |
24486291 | Crizotinib (PF-2341066) induces apoptosis due to downregulation of pSTAT3 and BCL-2 family proteins in NPM-ALK(+) anaplastic large cell lymphoma. | 2014 Apr |
1 |